Milestone Pharmaceuticals Inc. (MIST): Total Assets
$113.56M
As of 2025-12-31
$181.62M
As of 2026-06-30
+15.1%
3-year compound annual growth
-5.4%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $113.56M | +50.4% | 2026-03-20, Balance as of period end |
| 2024-12-31 | $75.50M | +0.4% | 2026-03-20, Balance as of period end |
| 2023-12-31 | $75.23M | +1.0% | 2025-03-13, Balance as of period end |
| 2022-12-31 | $74.48M | -37.9% | 2024-03-21, Balance as of period end |
| 2021-12-31 | $119.85M | -20.1% | 2023-03-29, Balance as of period end |
| 2020-12-31 | $149.97M | +21.5% | 2022-03-24, Balance as of period end |
| 2019-12-31 | $123.43M | +40.1% | 2021-03-29, Balance as of period end |
| 2018-12-31 | $88.08M | n/a | 2020-10-23, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | 2025-12-31 | $113.56M | +50.4% |
| Korro Bio, Inc. (KRRO) | 2025-12-31 | $113.51M | -49.8% |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | $114.11M | +17.8% |
| Rezolute, Inc. (RZLT) | 2026-06-30 | $112.85M | -35.7% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $116.46M | -22.7% |
| Sagimet Biosciences Inc. (SGMT) | 2025-12-31 | $116.48M | -27.3% |
| PMV Pharmaceuticals, Inc. (PMVP) | 2025-12-31 | $116.56M | -39.1% |
| Aardvark Therapeutics, Inc. (AARD) | 2025-12-31 | $117.18M | +51.2% |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | $117.81M | +50.4% |
Compare MIST, KRRO, RFL, RZLT side by side · Screen every company in Pharmaceutical Preparations ↗